Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-18 · accession 0001415889-25-004682 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-18 | TLSI | Szela Mary T | CEO AND Pres, Dir | A - Grant | $0.00 | +21.1K | 465.3K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | A | A | 21,089 | $0.00 | 465,348 | D | — | — | (F1) Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on such vesting date. |